DAV statement on Executive Order accelerating review of psychedelic therapies

DAV applauds the president’s executive order to accelerate research and expand access to innovative plant-based therapies for veterans living with the invisible wounds of war. For far too many veterans, conditions like post-traumatic stress and traumatic brain injury remain inadequately treated by conventional approaches, leaving them without timely or effective care.

This action represents a meaningful step toward closing that gap. By prioritizing rigorous research, streamlining clinical trials and reducing unnecessary barriers—including the need for veterans to seek care outside the United States—the administration is advancing a more responsive and veteran-centered system of care.

Veterans should not have to wait years for promising therapies to move through fragmented systems, nor should they be forced to navigate legal and logistical obstacles to access treatment. Stronger coordination across federal agencies and a clear commitment to scientific integrity are essential to delivering safe, effective options at the speed veterans deserve.

DAV and our partners will continue to press for policies that move beyond incremental change—ensuring that emerging psychedelic therapies are thoroughly studied, responsibly implemented and made accessible to the veterans who need them most.